Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
383.29 USD | +0.57% | -1.89% | +28.09% |
Dec. 02 | Morgan Stanley Upgrades Stryker to Overweight, Price Target is $445 | MT |
Nov. 19 | Stryker Unveils Oculan Lighting Platform to Enhance Surgical Visualization and Inumination | CI |
Capitalization | 145B 137B 127B 114B 205B 12,328B 225B 1,584B 585B 5,059B 546B 534B 21,943B | P/E ratio 2024 * |
39.3x | P/E ratio 2025 * | 33x |
---|---|---|---|---|---|
Enterprise value | 154B 146B 135B 120B 217B 13,065B 238B 1,678B 620B 5,361B 578B 566B 23,254B | EV / Sales 2024 * |
6.84x | EV / Sales 2025 * | 6.18x |
Free-Float |
-
| Yield 2024 * |
0.86% | Yield 2025 * | 0.92% |
Last Transcript: Stryker Corporation
1 day | +0.24% | ||
1 week | -2.13% | ||
Current month | -2.42% | ||
1 month | +1.00% | ||
3 months | +4.82% | ||
6 months | +9.90% | ||
Current year | +27.78% |
Director | Title | Age | Since |
---|---|---|---|
Kevin Lobo
CEO | Chief Executive Officer | 59 | 2012-09-30 |
Glenn Boehnlein
DFI | Director of Finance/CFO | 62 | 2016-03-31 |
Alan Douville
CTO | Chief Tech/Sci/R&D Officer | - | 2018-08-31 |
Manager | Title | Age | Since |
---|---|---|---|
Howard Cox
BRD | Director/Board Member | 80 | 1973-12-31 |
Ronda Stryker
BRD | Director/Board Member | 69 | 1983-12-31 |
Allan Golston
BRD | Director/Board Member | 57 | 2011-01-09 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.67% | 20 M€ | +16.38% | - | |
1.16% | 2 M€ | -1.17% | - |
Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
---|---|---|---|---|---|---|
+0.28% | -2.13% | +30.58% | +47.06% | 145B | ||
-0.08% | -0.34% | -5.45% | -19.43% | 11.06B | ||
+3.82% | -0.23% | +7.84% | -48.96% | 8.65B | ||
+0.33% | +2.83% | +123.30% | +238.70% | 7.64B | ||
+0.19% | -0.86% | +13.21% | -13.53% | 5.68B | ||
+0.75% | -.--% | +24.92% | +28.26% | 3.63B | ||
-1.55% | -4.96% | -5.76% | -65.81% | 2.65B | ||
+0.11% | +1.28% | -9.03% | -36.49% | 2.28B | ||
+1.52% | +4.70% | -15.29% | -34.81% | 1.84B | ||
+0.18% | -1.96% | -17.70% | -33.51% | 1.82B | ||
Average | +0.55% | +1.04% | +14.66% | +6.15% | 19.05B | |
Weighted average by Cap. | +0.38% | -1.45% | +28.67% | +40.23% |
2024 * | 2025 * | |
---|---|---|
Net sales | 22.52B 21.29B 19.75B 17.61B 31.8B 1,911B 34.84B 245B 90.63B 784B 84.57B 82.72B 3,401B | 24.41B 23.07B 21.4B 19.09B 34.47B 2,071B 37.77B 266B 98.24B 850B 91.67B 89.67B 3,687B |
Net income | 3.72B 3.52B 3.26B 2.91B 5.25B 316B 5.76B 40.56B 14.97B 130B 13.97B 13.67B 562B | 4.44B 4.19B 3.89B 3.47B 6.26B 376B 6.86B 48.35B 17.85B 154B 16.66B 16.29B 670B |
Net Debt | 8.68B 8.2B 7.61B 6.79B 12.26B 737B 13.43B 94.61B 34.93B 302B 32.59B 31.88B 1,311B | 5.57B 5.26B 4.88B 4.36B 7.87B 473B 8.62B 60.71B 22.41B 194B 20.92B 20.46B 841B |
Date | Price | Change | Volume |
---|---|---|---|
24-12-10 | 383.29 $ | +0.57% | 621,943 |
24-12-09 | 381.11 $ | -1.02% | 924,899 |
24-12-06 | 385.02 $ | +0.67% | 1,049,412 |
24-12-05 | 382.45 $ | -1.88% | 1,319,513 |
24-12-04 | 389.76 $ | -0.31% | 707,714 |
Delayed Quote Nyse, December 10, 2024 at 11:04 am EST
More quotesQuarterly revenue - Rate of surprise
- Stock Market
- Equities
- SYK Stock